Niagen Bioscience NAGE
NASDAQ NAGE
$2.95 +0.00 (+0.00%)
As of: Sep 30, 2026 · 12:18 PM EDT

Niagen Bioscience, Inc. (NAGE) EV to EBITDA (2016 - 2026)

Updated

Niagen Bioscience's EV to EBITDA came in at 15.98 for Q2 2026, down 74.3% from 62.25 a year earlier and down 21.4% from the prior quarter.

Analysis

Niagen Bioscience, Inc. (NAGE) EV to EBITDA (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Niagen Bioscience reported EV to EBITDA of -0.92; for FY2025, it came in at 25.91, down 39.5% from FY2024.

  • Going back by year, EV to EBITDA was 42.85 in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EV to EBITDA in data going back to Q2 2016.
  • Year-over-year, EV to EBITDA has declined for four consecutive quarters, with an average decline of 59.3% over the last four quarters.
  • Business Quant data shows NAGE's EV to EBITDA at 20.33 (Q1 2026), 25.91 (Q4 2025) and 33.80 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.98
Mar 31, 2026 20.33
Dec 31, 2025 25.91
Sep 30, 2025 33.80
Jun 30, 2025 62.25
Mar 31, 2025 34.63
Dec 31, 2024 42.85
Sep 30, 2024 190.30
Jul 2, 2016 177.01
API Access

Niagen Bioscience, Inc. EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NAGE&period=max&api_key=YOUR_API_KEY